Section of Hematology, Makati Medical Center, Makati, Philippines
Research Article
Use of Convalescent Plasma Therapy with Best Available Treatment (BAT) among Hospitalized COVID-19 Patients: A Multi-Center Study
Author(s): Flordeluna Z Mesina*, Jomell C Julian, Jesus Relos, Rosalio Torres, Maureen Via M Comia, June Marie P Ongkingco and Jimmy R. Lafavilla
Introduction: The Novel Coronavirus (COVID-19) has gripped our country with strain as well as effecting our health system. Currently, there are no standard guidelines in its treatment but the possible benefits of convalescent plasma in limiting complications and treating COVID-19 disease is being looked upon.
Objective: This study aims to determine the effectiveness and safety of using convalescent plasma in improving clinical course of hospitalized patients diagnosed with COVID-19.
Methods: This is a quasi-experimental (prospective analytical) multi-center study of 65 patients who received convalescent plasma therapy (CPT).
Results: Median age of patients who were given CPT was 60 years, were predominantly male (68%), and presented with severe COVID-19 pneumonia. Median hemoglobin presen.. Read More»
DOI:
10.37421/2165-7831.2022.12.288
Journal of Blood & Lymph received 443 citations as per Google Scholar report